 | • レポートコード：D0GIR-05121 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザNA阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザNA阻害剤の種類別市場規模（ザナミビル、オセルタミビル、ペラミビル）、用途別市場規模（A型インフルエンザ治療、B型インフルエンザ治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Green Cross、NeoPharm、Henan DaKen Chemical、Roche、Shionogi Co.、GlaxoSmithKline、Chemwill Asia Co.,Ltd.、ATK Chemical、Moksha8 Pharma ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザNA阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザNA阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザNA阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザNA阻害剤の南米市場（ブラジル、アルゼンチン） ・インフルエンザNA阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ザナミビル、オセルタミビル、ペラミビル ・用途別分析：A型インフルエンザ治療、B型インフルエンザ治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Influenza NA Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Influenza NA Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Influenza NA Inhibitor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Influenza NA Inhibitor market has been segmented into
Zanamivir
Oseltamivir
Peramivir
By Application, Influenza NA Inhibitor has been segmented into:
Influenza A Treatment
Influenza B Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza NA Inhibitor market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza NA Inhibitor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza NA Inhibitor market.
The report offers in-depth assessment of the growth and other aspects of the Influenza NA Inhibitor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Influenza NA Inhibitor Market Share Analysis
Influenza NA Inhibitor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenza NA Inhibitor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza NA Inhibitor sales, revenue and market share for each player covered in this report.
The major players covered in Influenza NA Inhibitor are:
Green Cross
NeoPharm
Henan DaKen Chemical
Roche
Shionogi Co.
GlaxoSmithKline
Chemwill Asia Co.,Ltd.
ATK Chemical
Moksha8 Pharma
Among other players domestic and global, Influenza NA Inhibitor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza NA Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza NA Inhibitor, with price, sales, revenue and global market share of Influenza NA Inhibitor in 2018 and 2019.
Chapter 3, the Influenza NA Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza NA Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Influenza NA Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Influenza NA Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Influenza NA Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza NA Inhibitor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza NA Inhibitor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Overview of Global Influenza NA Inhibitor Market
1.4.1 Global Influenza NA Inhibitor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Green Cross
2.1.1 Green Cross Details
2.1.2 Green Cross Major Business
2.1.3 Green Cross SWOT Analysis
2.1.4 Green Cross Product and Services
2.1.5 Green Cross Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 NeoPharm
2.2.1 NeoPharm Details
2.2.2 NeoPharm Major Business
2.2.3 NeoPharm SWOT Analysis
2.2.4 NeoPharm Product and Services
2.2.5 NeoPharm Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Henan DaKen Chemical
2.3.1 Henan DaKen Chemical Details
2.3.2 Henan DaKen Chemical Major Business
2.3.3 Henan DaKen Chemical SWOT Analysis
2.3.4 Henan DaKen Chemical Product and Services
2.3.5 Henan DaKen Chemical Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shionogi Co.
2.5.1 Shionogi Co. Details
2.5.2 Shionogi Co. Major Business
2.5.3 Shionogi Co. SWOT Analysis
2.5.4 Shionogi Co. Product and Services
2.5.5 Shionogi Co. Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Product and Services
2.6.4 GlaxoSmithKline Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chemwill Asia Co.,Ltd.
2.7.1 Chemwill Asia Co.,Ltd. Details
2.7.2 Chemwill Asia Co.,Ltd. Major Business
2.7.3 Chemwill Asia Co.,Ltd. Product and Services
2.7.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ATK Chemical
2.8.1 ATK Chemical Details
2.8.2 ATK Chemical Major Business
2.8.3 ATK Chemical Product and Services
2.8.4 ATK Chemical Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Moksha8 Pharma
2.9.1 Moksha8 Pharma Details
2.9.2 Moksha8 Pharma Major Business
2.9.3 Moksha8 Pharma Product and Services
2.9.4 Moksha8 Pharma Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Influenza NA Inhibitor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Influenza NA Inhibitor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza NA Inhibitor Manufacturer Market Share in 2019
3.3.2 Top 6 Influenza NA Inhibitor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Influenza NA Inhibitor Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza NA Inhibitor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Influenza NA Inhibitor Revenue and Market Share by Regions (2015-2020)
4.2 North America Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
4.3 Europe Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
4.5 South America Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Influenza NA Inhibitor Sales, Revenue and Market Share by Country
5.1.1 North America Influenza NA Inhibitor Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenza NA Inhibitor Revenue and Market Share by Country (2015-2020)
5.2 United States Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
5.3 Canada Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
5.4 Mexico Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Influenza NA Inhibitor Sales, Revenue and Market Share by Country
6.1.1 Europe Influenza NA Inhibitor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Influenza NA Inhibitor Revenue and Market Share by Country (2015-2020)
6.2 Germany Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
6.3 UK Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
6.4 France Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
6.5 Russia Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
6.6 Italy Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenza NA Inhibitor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Influenza NA Inhibitor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Influenza NA Inhibitor Revenue and Market Share by Regions (2015-2020)
7.2 China Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7.3 Japan Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7.4 Korea Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7.5 India Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
7.7 Australia Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Influenza NA Inhibitor Sales, Revenue and Market Share by Country
8.1.1 South America Influenza NA Inhibitor Sales and Market Share by Country (2015-2020)
8.1.2 South America Influenza NA Inhibitor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
8.3 Argentina Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenza NA Inhibitor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Influenza NA Inhibitor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Influenza NA Inhibitor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
9.3 Turkey Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
9.4 Egypt Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
9.5 South Africa Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Influenza NA Inhibitor Sales and Market Share by Type (2015-2020)
10.2 Global Influenza NA Inhibitor Revenue and Market Share by Type (2015-2020)
10.3 Global Influenza NA Inhibitor Price by Type (2015-2020)
11 Global Influenza NA Inhibitor Market Segment by Application
11.1 Global Influenza NA Inhibitor Sales Market Share by Application (2015-2020)
11.2 Global Influenza NA Inhibitor Revenue Market Share by Application (2015-2020)
11.3 Global Influenza NA Inhibitor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Influenza NA Inhibitor Sales, Revenue and Growth Rate (2021-2025)
12.2 Influenza NA Inhibitor Market Forecast by Regions (2021-2025)
12.2.1 North America Influenza NA Inhibitor Market Forecast (2021-2025)
12.2.2 Europe Influenza NA Inhibitor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Influenza NA Inhibitor Market Forecast (2021-2025)
12.2.4 South America Influenza NA Inhibitor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Influenza NA Inhibitor Market Forecast (2021-2025)
12.3 Influenza NA Inhibitor Market Forecast by Type (2021-2025)
12.3.1 Global Influenza NA Inhibitor Sales Forecast by Type (2021-2025)
12.3.2 Global Influenza NA Inhibitor Market Share Forecast by Type (2021-2025)
12.4 Influenza NA Inhibitor Market Forecast by Application (2021-2025)
12.4.1 Global Influenza NA Inhibitor Sales Forecast by Application (2021-2025)
12.4.2 Global Influenza NA Inhibitor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Influenza NA Inhibitor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza NA Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza NA Inhibitor Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Influenza NA Inhibitor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Green Cross Basic Information, Manufacturing Base and Competitors
Table 9. Green Cross Influenza NA Inhibitor Major Business
Table 10. Green Cross Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 11. Green Cross SWOT Analysis
Table 12. Green Cross Influenza NA Inhibitor Product and Services
Table 13. Green Cross Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. NeoPharm Basic Information, Manufacturing Base and Competitors
Table 15. NeoPharm Influenza NA Inhibitor Major Business
Table 16. NeoPharm Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 17. NeoPharm SWOT Analysis
Table 18. NeoPharm Influenza NA Inhibitor Product and Services
Table 19. NeoPharm Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Henan DaKen Chemical Basic Information, Manufacturing Base and Competitors
Table 21. Henan DaKen Chemical Influenza NA Inhibitor Major Business
Table 22. Henan DaKen Chemical Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 23. Henan DaKen Chemical SWOT Analysis
Table 24. Henan DaKen Chemical Influenza NA Inhibitor Product and Services
Table 25. Henan DaKen Chemical Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Roche Basic Information, Manufacturing Base and Competitors
Table 27. Roche Influenza NA Inhibitor Major Business
Table 28. Roche Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 29. Roche SWOT Analysis
Table 30. Roche Influenza NA Inhibitor Product and Services
Table 31. Roche Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Shionogi Co. Basic Information, Manufacturing Base and Competitors
Table 33. Shionogi Co. Influenza NA Inhibitor Major Business
Table 34. Shionogi Co. Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 35. Shionogi Co. SWOT Analysis
Table 36. Shionogi Co. Influenza NA Inhibitor Product and Services
Table 37. Shionogi Co. Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Influenza NA Inhibitor Major Business
Table 40. GlaxoSmithKline Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 41. GlaxoSmithKline SWOT Analysis
Table 42. GlaxoSmithKline Influenza NA Inhibitor Product and Services
Table 43. GlaxoSmithKline Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Chemwill Asia Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 45. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Major Business
Table 46. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 47. Chemwill Asia Co.,Ltd. SWOT Analysis
Table 48. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Product and Services
Table 49. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. ATK Chemical Basic Information, Manufacturing Base and Competitors
Table 51. ATK Chemical Influenza NA Inhibitor Major Business
Table 52. ATK Chemical Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 53. ATK Chemical SWOT Analysis
Table 54. ATK Chemical Influenza NA Inhibitor Product and Services
Table 55. ATK Chemical Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Moksha8 Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Moksha8 Pharma Influenza NA Inhibitor Major Business
Table 58. Moksha8 Pharma Influenza NA Inhibitor Total Revenue (USD Million) (2018-2019)
Table 59. Moksha8 Pharma SWOT Analysis
Table 60. Moksha8 Pharma Influenza NA Inhibitor Product and Services
Table 61. Moksha8 Pharma Influenza NA Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Influenza NA Inhibitor Sales by Manufacturer (2018-2019) (Kilotons)
Table 63. Global Influenza NA Inhibitor Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Influenza NA Inhibitor Sales by Regions (2015-2020) (Kilotons)
Table 65. Global Influenza NA Inhibitor Sales Market Share by Regions (2015-2020)
Table 66. Global Influenza NA Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Influenza NA Inhibitor Sales by Countries (2015-2020) (Kilotons)
Table 68. North America Influenza NA Inhibitor Sales Market Share by Countries (2015-2020)
Table 69. North America Influenza NA Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020)
Table 71. Europe Influenza NA Inhibitor Sales by Countries (2015-2020) (Kilotons)
Table 72. Europe Influenza NA Inhibitor Sales Market Share by Countries (2015-2020)
Table 73. Europe Influenza NA Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Influenza NA Inhibitor Sales by Regions (2015-2020) (Kilotons)
Table 75. Asia-Pacific Influenza NA Inhibitor Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Influenza NA Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Influenza NA Inhibitor Sales by Countries (2015-2020) (Kilotons)
Table 78. South America Influenza NA Inhibitor Sales Market Share by Countries (2015-2020)
Table 79. South America Influenza NA Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Influenza NA Inhibitor Sales by Countries (2015-2020) (Kilotons)
Table 82. Middle East & Africa Influenza NA Inhibitor Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Influenza NA Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020)
Table 85. Global Influenza NA Inhibitor Sales by Type (2015-2020) (Kilotons)
Table 86. Global Influenza NA Inhibitor Sales Share by Type (2015-2020)
Table 87. Global Influenza NA Inhibitor Revenue by Type (2015-2020) (USD Million)
Table 88. Global Influenza NA Inhibitor Revenue Share by Type (2015-2020)
Table 89. Global Influenza NA Inhibitor Sales by Application (2015-2020) (Kilotons)
Table 90. Global Influenza NA Inhibitor Sales Share by Application (2015-2020)
Table 91. Global Influenza NA Inhibitor Sales Forecast by Regions (2021-2025) (Kilotons)
Table 92. Global Influenza NA Inhibitor Market Share Forecast by Regions (2021-2025)
Table 93. Global Influenza NA Inhibitor Sales Forecast by Type (2021-2025) (Kilotons)
Table 94. Global Influenza NA Inhibitor Market Share Forecast by Type (2021-2025)
Table 95. Global Influenza NA Inhibitor Sales Forecast by Application (2021-2025)
Table 96. Global Influenza NA Inhibitor Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Influenza NA Inhibitor Picture
Figure 2. Global Sales Market Share of Influenza NA Inhibitor by Type in 2019
Figure 3. Zanamivir Picture
Figure 4. Oseltamivir Picture
Figure 5. Peramivir Picture
Figure 6. Influenza NA Inhibitor Sales Market Share by Application in 2019
Figure 7. Influenza A Treatment Picture
Figure 8. Influenza B Treatment Picture
Figure 9. Global Influenza NA Inhibitor Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Influenza NA Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Influenza NA Inhibitor Sales Market Share by Manufacturer in 2019
Figure 30. Global Influenza NA Inhibitor Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Influenza NA Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Influenza NA Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 35. Global Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Influenza NA Inhibitor Revenue Market Share by Regions (2015-2020)
Figure 37. Global Influenza NA Inhibitor Revenue Market Share by Regions in 2018
Figure 38. North America Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
Figure 39. Europe Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
Figure 41. South America Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Influenza NA Inhibitor Sales and Growth Rate (2015-2020)
Figure 43. North America Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Influenza NA Inhibitor Sales Market Share by Countries (2015-2020)
Figure 45. North America Influenza NA Inhibitor Sales Market Share by Countries in 2018
Figure 46. North America Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Influenza NA Inhibitor Revenue Market Share by Countries in 2018
Figure 48. United States Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 49. Canada Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 50. Mexico Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 51. Europe Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Influenza NA Inhibitor Revenue Market Share by Countries in 2019
Figure 54. Germany Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 55. UK Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 56. France Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 57. Russia Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 58. Italy Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 59. Asia-Pacific Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Influenza NA Inhibitor Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Influenza NA Inhibitor Revenue Market Share by Regions 2019
Figure 62. China Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 63. Japan Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 64. Korea Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 65. India Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 66. Southeast Asia Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 67. South America Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Influenza NA Inhibitor Sales Market Share by Countries in 2019
Figure 69. South America Influenza NA Inhibitor Revenue Market Share by Countries in 2019
Figure 70. Brazil Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 71. Argentina Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 72. Middle East and Africa Influenza NA Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 77. Egypt Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 78. Turkey Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 79. South Africa Influenza NA Inhibitor Sales and Growth Rate (2015-2020) (Kilotons)
Figure 80. Global Influenza NA Inhibitor Sales and Growth Rate (2021-2025) (Kilotons)
Figure 81. Global Influenza NA Inhibitor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Influenza NA Inhibitor Market Forecast (2021-2025) (Kilotons)
Figure 83. Europe Sales Influenza NA Inhibitor Market Forecast (2021-2025) (Kilotons)
Figure 84. Asia-Pacific Sales Influenza NA Inhibitor Market Forecast (2021-2025) (Kilotons)
Figure 85. South America Sales Influenza NA Inhibitor Market Forecast (2021-2025) (Kilotons)
Figure 86. Middle East & Africa Sales Influenza NA Inhibitor Market Forecast (2021-2025) (Kilotons)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Influenza Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 654.9 million by 2025, from USD 545.7 million in 2019. The Influenza Medicat…- インフルエンザワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 一般インフルエンザ診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The General Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- インフルエンザウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza Virus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…